Banzai CEO Purchases Additional Shares in Market
SEATTLE, Dec. 21, 2023 (GLOBE NEWSWIRE) — Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology […]
Mineralys Therapeutics Announces First Subject Dosed in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of Hypertension
– Topline data from confirmatory Launch-HTN trial expected in 2H 2025 – – Topline data from ongoing Advance-HTN pivotal trial […]
Capital Product Partners L.P. Announces Closing of Transaction to Acquire 11 Newbuild LNG Carriers Pursuant to Umbrella Agreement
ATHENS, Greece, Dec. 21, 2023 (GLOBE NEWSWIRE) — Capital Product Partners L.P. (the “Partnership”, “CPLP”, or “we”/ “us”) (NASDAQ:CPLP) today […]
Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference
REDWOOD CITY, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a […]
Topline Results from MYLOX-1 Trial Demonstrate Reduction in Fibrosis of the Bone Marrow in Patients with Myelofibrosis
BOSTON, Dec. 21, 2023 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development […]
Mission Produce(TM) Announces Fiscal 2023 Fourth Quarter Financial Results
OXNARD, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) — Mission Produce, Inc. (Nasdaq: AVO) (“Mission” or the “Company”), a world leader […]
Credit Acceptance Announces Completion of $294.0 Million Asset-Backed Financing
Southfield, Michigan , Dec. 21, 2023 (GLOBE NEWSWIRE) — Credit Acceptance Corporation (Nasdaq: CACC) (the “Company”, “Credit Acceptance”, “we”, “our”, […]
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Dec. 21, 2023 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today […]
Biodexa Announces Closing Of $6.0 Million Underwritten Public Offering, Including Full Exercise Of Overallotment Option
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Announces Closing Of $6.0 Million Underwritten Public Offering, Including Full Exercise Of Overallotment […]
NorthEast Community Bancorp, Inc. Announces Quarterly Cash Dividend
WHITE PLAINS, N.Y., Dec. 21, 2023 (GLOBE NEWSWIRE) — NorthEast Community Bancorp, Inc. (the “Company”) (Nasdaq: NECB) announced today that […]
